TheraTech Inc. announced that it has filed a registrationstatement with the Securities and Exchange Commission for asecondary public offering of 1.25 million shares of commonstock. The offering will be co-managed by William Blair & Co.and Vector Securities International Inc.

The Salt Lake City drug delivery company (NASDAQ:THRT) willuse the proceeds to fund R&D, as well as for construction ofadditional R&D and manufacturing facilities. TheraTech has sixdrug delivery products in clinical trials currently.

(c) 1997 American Health Consultants. All rights reserved.